Viral Vector Manufacturing Market Report: Trends, Forecast and Competitive Analysis to 2030
Get it in 2 to 4 weeks by ordering today
Viral Vector Manufacturing Trends and Forecast
The future of the global viral vector manufacturing market looks promising with opportunities in the pharmaceutical & biopharmaceutical and research institutes markets.The global viral vector manufacturing market is expected t%li%reach an estimated $4.3 billion by 2030, and it is forecast t%li%grow at a CAGR of 16.7% from 2024 t%li%2030. The major drivers for this market are increasing demand for viral vector-based therapies, growing investment in viral vector manufacturing, and technological advancements in viral vector manufacturing.
A more than 150-page report is developed t%li%help in your business decisions. Sample figures with some insights are shown below.
Viral Vector Manufacturing by Segment
The study includes a forecast for the global viral vector manufacturing by type, workflow, application, end use, and region.
Viral Vector Manufacturing Market by Type [Shipment Analysis by Value from 2018 t%li%2030]:
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies viral vector manufacturing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the viral vector manufacturing companies profiled in this report include-
Q.1 What is the viral vector manufacturing market size?
Answer:The global viral vector manufacturing market is expected t%li%reach an estimated $4.3 billion by 2030.
Q.2 What is the growth forecast for viral vector manufacturing market?
Answer:The global viral vector manufacturing market is expected t%li%grow with a CAGR of 16.7% from 2024 t%li%2030.
Q.3 What are the major drivers influencing the growth of the viral vector manufacturing market?
Answer:The major drivers for this market are increasing demand for viral vector-based therapies, growing investment in viral vector manufacturing and technological advancements in viral vector manufacturing.
Q4. What are the major segments for viral vector manufacturing market?
Answer:The future of the viral vector manufacturing market looks promising with opportunities in the pharmaceutical & biopharmaceutical and research institutes markets.
Q5. Wh%li%are the key viral vector manufacturing market companies?
Answer:Some of the key viral vector manufacturing companies are as follows:
Answer:Lucintel forecasts that cell and gene therapy is expected t%li%witness highest growth over the forecast period due t%li%growing demand for cell and gene therapies for the treatment of a wide range of diseases, including cancer, rare diseases, and genetic disorders.
Q7. In viral vector manufacturing market, which region is expected t%li%be the largest in next 5 years?
Answer:North America is expected t%li%witness highest growth over the forecast period due t%li%increasing demand for viral vector-based therapies from the pharmaceutical and biotechnology industries in the region.
Q.8 D%li%we receive customization in this report?
Answer:Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the viral vector manufacturing market by type (adenovirus, retrovirus, adeno-associated virus, lentivirus, plasmid DNA, and others), workflow (upstream manufacturing and downstream manufacturing), application (cell & gene therapy, vaccinology, and research & other applications), end use (pharmaceutical & biopharmaceutical, research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Wh%li%are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat d%li%they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related t%li%Viral Vector Manufacturing Market, Viral Vector Manufacturing Market Size, Viral Vector Manufacturing Market Growth, Viral Vector Manufacturing Market Analysis, Viral Vector Manufacturing Market Report, Viral Vector Manufacturing Market Share, Viral Vector Manufacturing Market Trends, Viral Vector Manufacturing Market Forecast, Viral Vector Manufacturing Companies, write Lucintel analyst at email: [email protected]. We will be glad t%li%get back t%li%you soon.
Viral Vector Manufacturing Trends and Forecast
The future of the global viral vector manufacturing market looks promising with opportunities in the pharmaceutical & biopharmaceutical and research institutes markets.The global viral vector manufacturing market is expected t%li%reach an estimated $4.3 billion by 2030, and it is forecast t%li%grow at a CAGR of 16.7% from 2024 t%li%2030. The major drivers for this market are increasing demand for viral vector-based therapies, growing investment in viral vector manufacturing, and technological advancements in viral vector manufacturing.
A more than 150-page report is developed t%li%help in your business decisions. Sample figures with some insights are shown below.
Viral Vector Manufacturing by Segment
The study includes a forecast for the global viral vector manufacturing by type, workflow, application, end use, and region.
Viral Vector Manufacturing Market by Type [Shipment Analysis by Value from 2018 t%li%2030]:
- Adenovirus
- Retrovirus
- Adeno-Associated Virus
- Lentivirus
- Plasmid DNA
- Others
- Upstream Manufacturing
- Downstream Manufacturing
- Cell & Gene Therapy
- Vaccinology
- Research & Other Applications
- Pharmaceutical & Biopharmaceutical
- Research Institutes
- Others
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies viral vector manufacturing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the viral vector manufacturing companies profiled in this report include-
- Merck
- Lonza
- Fujifilm Diosynth Biotechnologies
- Therm%li%Fisher Scientific
- Cobra Biologics
- Catalent
- Wuxi Biologics
- Takara Bio
- Waisman Biomanufacturing
- Genezen Laboratories
- Lucintel forecasts that cell and gene therapy is expected t%li%witness highest growth over the forecast period due t%li%growing demand for cell and gene therapies for the treatment of a wide range of diseases, including cancer, rare diseases, and genetic disorders.
- Within this market, pharmaceutical and biopharmaceutical will remain the largest segment due t%li%the fact that these pharmaceutical and biopharmaceutical companies companies are developing and commercializing viral vector-based therapies for a wide range of diseases, including cancer, rare diseases, and infectious diseases.
- North America is expected t%li%witness highest growth over the forecast period due t%li%increasing demand for viral vector-based therapies from the pharmaceutical and biotechnology industries in the region.
- Market Size Estimates: Viral vector manufacturing market size estimation in terms of value ($B).
- Trend and Forecast Analysis: Market trends (2018 t%li%2023) and forecast (2024 t%li%2030) by various segments and regions.
- Segmentation Analysis: Viral vector manufacturing market size by various segments, such as by type, workflow, application, end use, and region in terms of value ($B).
- Regional Analysis: Viral vector manufacturing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different types, workflows, applications, end uses, and regions for the viral vector manufacturing market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the viral vector manufacturing market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q.1 What is the viral vector manufacturing market size?
Answer:The global viral vector manufacturing market is expected t%li%reach an estimated $4.3 billion by 2030.
Q.2 What is the growth forecast for viral vector manufacturing market?
Answer:The global viral vector manufacturing market is expected t%li%grow with a CAGR of 16.7% from 2024 t%li%2030.
Q.3 What are the major drivers influencing the growth of the viral vector manufacturing market?
Answer:The major drivers for this market are increasing demand for viral vector-based therapies, growing investment in viral vector manufacturing and technological advancements in viral vector manufacturing.
Q4. What are the major segments for viral vector manufacturing market?
Answer:The future of the viral vector manufacturing market looks promising with opportunities in the pharmaceutical & biopharmaceutical and research institutes markets.
Q5. Wh%li%are the key viral vector manufacturing market companies?
Answer:Some of the key viral vector manufacturing companies are as follows:
- Merck
- Lonza
- Fujifilm Diosynth Biotechnologies
- Therm%li%Fisher Scientific
- Cobra Biologics
- Catalent
- Wuxi Biologics
- Takara Bio
- Waisman Biomanufacturing
- Genezen Laboratories
Answer:Lucintel forecasts that cell and gene therapy is expected t%li%witness highest growth over the forecast period due t%li%growing demand for cell and gene therapies for the treatment of a wide range of diseases, including cancer, rare diseases, and genetic disorders.
Q7. In viral vector manufacturing market, which region is expected t%li%be the largest in next 5 years?
Answer:North America is expected t%li%witness highest growth over the forecast period due t%li%increasing demand for viral vector-based therapies from the pharmaceutical and biotechnology industries in the region.
Q.8 D%li%we receive customization in this report?
Answer:Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the viral vector manufacturing market by type (adenovirus, retrovirus, adeno-associated virus, lentivirus, plasmid DNA, and others), workflow (upstream manufacturing and downstream manufacturing), application (cell & gene therapy, vaccinology, and research & other applications), end use (pharmaceutical & biopharmaceutical, research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Wh%li%are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat d%li%they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related t%li%Viral Vector Manufacturing Market, Viral Vector Manufacturing Market Size, Viral Vector Manufacturing Market Growth, Viral Vector Manufacturing Market Analysis, Viral Vector Manufacturing Market Report, Viral Vector Manufacturing Market Share, Viral Vector Manufacturing Market Trends, Viral Vector Manufacturing Market Forecast, Viral Vector Manufacturing Companies, write Lucintel analyst at email: [email protected]. We will be glad t%li%get back t%li%you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL VIRAL VECTOR MANUFACTURING MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1: Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2: Global Viral Vector Manufacturing Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Viral Vector Manufacturing Market by Type
3.3.1: Adenovirus
3.3.2: Retrovirus
3.3.3: Adeno-Associated Virus
3.3.4: Lentivirus
3.3.5: Plasmid DNA
3.3.6: Others
3.4: Global Viral Vector Manufacturing Market by Workflow
3.4.1: Upstream Manufacturing
3.4.2: Downstream Manufacturing
3.5: Global Viral Vector Manufacturing Market by Application
3.5.1: Cell & Gene Therapy
3.5.2: Vaccinology
3.5.3: Research & Other Applications
3.6: Global Viral Vector Manufacturing Market by End Use
3.6.1: Pharmaceutical & Biopharmaceutical
3.6.2: Research Institutes
3.6.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Viral Vector Manufacturing Market by Region
4.2: North American Viral Vector Manufacturing Market
4.2.1: North American Viral Vector Manufacturing Market by End Use: Pharmaceutical & Biopharmaceutical, Research Institutes, and Others
4.3: European Viral Vector Manufacturing Market
4.3.1: European Viral Vector Manufacturing Market by Application: Cell & Gene Therapy, Vaccinology, and Research & Other Applications
4.3.2: European Viral Vector Manufacturing Market by End Use: Pharmaceutical & Biopharmaceutical, Research Institutes, and Others
4.4: APAC Viral Vector Manufacturing Market
4.4.1: APAC Viral Vector Manufacturing Market by Application: Cell & Gene Therapy, Vaccinology, and Research & Other Applications
4.4.2: APAC Viral Vector Manufacturing Market by End Use: Pharmaceutical & Biopharmaceutical, Research Institutes, and Others
4.5: ROW Viral Vector Manufacturing Market
4.5.1: ROW Viral Vector Manufacturing Market by Application: Cell & Gene Therapy, Vaccinology, and Research & Other Applications
4.5.2: ROW Viral Vector Manufacturing Market by End Use: Pharmaceutical & Biopharmaceutical, Research Institutes, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Viral Vector Manufacturing Market by Type
6.1.2: Growth Opportunities for the Global Viral Vector Manufacturing Market by Workflow
6.1.3: Growth Opportunities for the Global Viral Vector Manufacturing Market by Application
6.1.4: Growth Opportunities for the Global Viral Vector Manufacturing Market by End Use
6.1.5: Growth Opportunities for the Global Viral Vector Manufacturing Market by Region
6.2: Emerging Trends in the Global Viral Vector Manufacturing Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Viral Vector Manufacturing Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Viral Vector Manufacturing Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Merck
7.2: Lonza
7.3: FUJIFILM Diosynth Biotechnologies
7.4: Thermo Fisher Scientific
7.5: Cobra Biologics
7.6: Catalent
7.7: Wuxi Biologics
7.8: Takara Bio
7.9: Waisman Biomanufacturing
7.10: Genezen laboratories
2. GLOBAL VIRAL VECTOR MANUFACTURING MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1: Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2: Global Viral Vector Manufacturing Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Viral Vector Manufacturing Market by Type
3.3.1: Adenovirus
3.3.2: Retrovirus
3.3.3: Adeno-Associated Virus
3.3.4: Lentivirus
3.3.5: Plasmid DNA
3.3.6: Others
3.4: Global Viral Vector Manufacturing Market by Workflow
3.4.1: Upstream Manufacturing
3.4.2: Downstream Manufacturing
3.5: Global Viral Vector Manufacturing Market by Application
3.5.1: Cell & Gene Therapy
3.5.2: Vaccinology
3.5.3: Research & Other Applications
3.6: Global Viral Vector Manufacturing Market by End Use
3.6.1: Pharmaceutical & Biopharmaceutical
3.6.2: Research Institutes
3.6.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Viral Vector Manufacturing Market by Region
4.2: North American Viral Vector Manufacturing Market
4.2.1: North American Viral Vector Manufacturing Market by End Use: Pharmaceutical & Biopharmaceutical, Research Institutes, and Others
4.3: European Viral Vector Manufacturing Market
4.3.1: European Viral Vector Manufacturing Market by Application: Cell & Gene Therapy, Vaccinology, and Research & Other Applications
4.3.2: European Viral Vector Manufacturing Market by End Use: Pharmaceutical & Biopharmaceutical, Research Institutes, and Others
4.4: APAC Viral Vector Manufacturing Market
4.4.1: APAC Viral Vector Manufacturing Market by Application: Cell & Gene Therapy, Vaccinology, and Research & Other Applications
4.4.2: APAC Viral Vector Manufacturing Market by End Use: Pharmaceutical & Biopharmaceutical, Research Institutes, and Others
4.5: ROW Viral Vector Manufacturing Market
4.5.1: ROW Viral Vector Manufacturing Market by Application: Cell & Gene Therapy, Vaccinology, and Research & Other Applications
4.5.2: ROW Viral Vector Manufacturing Market by End Use: Pharmaceutical & Biopharmaceutical, Research Institutes, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Viral Vector Manufacturing Market by Type
6.1.2: Growth Opportunities for the Global Viral Vector Manufacturing Market by Workflow
6.1.3: Growth Opportunities for the Global Viral Vector Manufacturing Market by Application
6.1.4: Growth Opportunities for the Global Viral Vector Manufacturing Market by End Use
6.1.5: Growth Opportunities for the Global Viral Vector Manufacturing Market by Region
6.2: Emerging Trends in the Global Viral Vector Manufacturing Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Viral Vector Manufacturing Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Viral Vector Manufacturing Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Merck
7.2: Lonza
7.3: FUJIFILM Diosynth Biotechnologies
7.4: Thermo Fisher Scientific
7.5: Cobra Biologics
7.6: Catalent
7.7: Wuxi Biologics
7.8: Takara Bio
7.9: Waisman Biomanufacturing
7.10: Genezen laboratories
